Expression of RUNX3 protein in human lung adenocarcinoma: Implications for tumor progression and prognosis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Science

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2005.00033.xPMID 15819721PMCID PMC11158107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Grade of stromal invasion in small adenocarcinoma of the lung : histopathological minimal invasion and prognosis

  2005cited by this paper
• Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

  2004cited by this paper
• Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

  2004cited by this paper
• Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

  2004cited by this paper
• Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma

  2004cited by this paper
• Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

  2004cited by this paper
• Grade of Stromal Invasion in Small Adenocarcinoma of the Lung: Histopathological Minimal Invasion and Prognosis

  2004cited by this paper
• Frequent Loss of RUNX3 Expression by Promoter Hypermethylation in Gastric Carcinoma

  2004cited by this paper
• Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples

  2003cited by this paper
• RUNX transcription factors as key targets of TGF-β superfamily signaling

  2003cited by this paper
• Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.

  2003cited by this paper
• Promoter methylation status of DAP‐kinase and RUNX3 genes in neoplastic and non‐neoplastic gastric epithelia

  2003cited by this paper
• RUNX transcription factors as key targets of TGF-beta superfamily signaling.

  2003cited by this paper
• Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers

  2003cited by this paper
• Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants.

  2003cited by this paper
• Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.

  2002cited by this paper
• Two major Smad pathways in TGF‐β superfamily signalling

  2002cited by this paper
• Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites

  2002cited by this paper
• Causal relationship between the loss of RUNX3 expression and gastric cancer.

  2002cited by this paper
• Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.

  2002cited by this paper
• The RUNX3 gene--sequence, structure and regulated expression.

  2001cited by this paper
• Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.

  2001cited by this paper
• Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.

  2001cited by this paper
• Transforming growth factor‐β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

  2001cited by this paper
• Interaction and Functional Cooperation of PEBP2/CBF with Smads

  1999cited by this paper
• Molecular basis of tissue‐specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF

  1999cited by this paper
• Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma

  1999cited by this paper
• p53 alterations in atypical alveolar hyperplasia of the human lung.

  1998cited by this paper
• A Large Variety of Alternatively Spliced and Differentially Expressed mRNAs Are Encoded by the Human Acute Myeloid Leukemia Gene AML1

  1996cited by this paper
• Small adenocarcinoma of the lung. Histologic characteristics and prognosis

  1995cited by this paper
• Surfactant apoprotein A (SP-A) is synthesized in airway cells.

  1990cited by this paper
• Alveolar epithelial hyperplasia and adenocarcinoma of the lung.

  1990cited by this paper
• Prognosis and survival in resected lung carcinoma based on the new international staging system.

  1988cited by this paper

• CD3+RUNX3+ lymphocyte density; an independent prognostic factor in colon and lung adenocarcinoma but not in lung squamous cell carcinoma

  2026cites this paper
• Single-Cell RNA Sequencing Reveals Potential Mechanism of RUNX3 Reshaping Tumor Microenvironment in Non-small-cell Lung Cancer

  2025cites this paper
• Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable".

  2023cites this paper
• Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis

  2021cites this paper
• Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night

  2020cites this paper
• MicroRNA‑629 inhibition suppresses the viability and invasion of non‑small cell lung cancer cells by directly targeting RUNX3.

  2019cites this paper
• Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients

  2019cites this paper
• Abstract. Dysregulated microRNAs (miRNAs/miRs) directly modulate the biological functions of non-small cell lung cancer (NSCLC) cells and contribute to the initiation and progression of NSCLC; however, the specific roles and underlying mechanisms of the dysregulated miRNAs

  2019cites this paper
• The Diagnostic and Therapeutic Potential of the Epigenetic Modifications of Lung Cancer–Related Genes

  2019cites this paper
• Molecular Pathology of RUNX 3 in Human Carcinogenesis

  2019cites this paper
• Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer

  2018cites this paper
• MicroRNA-18b promotes cell proliferation and invasion in non-small cell lung cancer by directly targeting runt-related transcription factor 3

  2018influential citation
• UnPAKing RUNX3 functions–Both sides of the coin

  2017cites this paper
• Immunohistochemical expression of RUNX 3 and p 21 WAF 1 / CIP 1 and its correlation with clinicopathologic parameters in breast carcinoma of Egyptian women

  2016cites this paper
• The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis

  2016cites this paper
• Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis

  2015cites this paper
• Clinicopathological significance and potential drug target of rUnX3 in non-small cell lung cancer: a meta-analysis the mechanism of initiation, progression, and identification of prognostic markers

  2015cites this paper
• miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3

  2015cites this paper
• Retrospective Study of Adjuvant Chemotherapy Effects on Survival Rate after Three-Field Lymph Node Dissection for Stage IIA Esophageal Cancer.

  2015cites this paper
• Clinicopathological significance and potential drug target of rUnX3 in non-small cell lung cancer: a meta-analysis the mechanism of initiation, progression, and identification of prognostic markers

  2015cites this paper
• Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma

  2014cites this paper
• Clinicopathological significance and potential drug target of RUNX3 in breast cancer

  2014cites this paper
• Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy

  2014cites this paper
• Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma

  2013cites this paper
• MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer

  2013cites this paper
• Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression

  2012cites this paper
• DNA Methylation of RUNX3 in Papillary Thyroid Cancer

  2012cites this paper
• RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status

  2012cites this paper
• Bioinformatics analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes.

  2012cites this paper
• Runt‐related transcription factor 3 reverses epithelial–mesenchymal transition in hepatocellular carcinoma

  2012cites this paper
• A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma

  2011cites this paper
• Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis

  2011cites this paper
• Oncogenic role of RUNX3 in head and neck cancer

  2011cites this paper
• Loss of runt‐related transcription factor 3 causes development and progression of hepatocellular carcinoma

  2011cites this paper
• Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma

  2011cites this paper
• Loss of runt-related transcription factor 3 expression associated with human hepatocellular carcinoma progression and prognosis.

  2011influential citation
• Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function

  2011cites this paper
• Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma.

  2011cites this paper
• RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.

  2010cites this paper
• The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome

  2009cites this paper
• Molecular pathology of RUNX3 in human carcinogenesis.

  2009cites this paper
• Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma

  2009cites this paper
• Expression of RUNX3 in salivary adenoid cystic carcinoma: Implications for tumor progression and prognosis

  2008cites this paper
• Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

  2007cites this paper
• Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer

  2007cites this paper
• Expression of RUNX3 Protein in Human Esophageal Mucosa and Squamous Cell Carcinoma

  2006cites this paper
• Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes

  2004cites this paper